Headshot photo of Jesse Keller, M.D., M.C.R.

Jesse Keller, M.D., M.C.R.

  • Associate Professor of Dermatology, School of Medicine


Dr. Keller is a board-certified dermatologist that specializes in general and complex dermatology with special interests in dermatologic urgent care and inpatient consultation. He provides a consistent and accessible dermatologic resource for providers who see patients in the hospital setting. Dr. Keller sees patients at the Department of Dermatology at the Center for Health & Healing and at both the OHSU and the Portland Veterans Affairs hospitals. 

At the OHSU Department of Dermatology, he aims to provide rapid and effective triage for urgently arising outpatient skin problems. In the hospital, he consults on patients with a broad range of conditions, from common (stasis dermatitis, cellulitis, shingles) to more serious (pyoderma gangrenosum, autoimmune blistering dermatoses, graft-versus-host disease). His research interests include the use of inpatient telemedicine, Stevens-Johnson syndrome, DRESS syndrome, calciphylaxis, and prurigo nodularis. One of his career focuses is increasing the amount of interaction and education between dermatology and the other medical specialties.

In his free time, Dr. Keller enjoys time with his spouse, son, and shih-poo named Mo.

Education and training

    • M.D., 2011, University of Washington
    • M.C.R., 2020, Oregon Health & Science University
  • Internship

    • Internal Medicine at Providence Portland Medical Center, Portland, OR, 2012
  • Residency

    • Case Western Reserve University, Cleveland, OH, 2015
  • Certifications

    • American Board of Dermatology

Memberships and associations:

  • Society of Dermatology Hospitalists
  • Oregon Dermatology Society
  • Oregon Medical Association
  • Medical Dermatology Society
  • Women’s Dermatologic Society
  • American Academy of Dermatology

Areas of interest

  • Inpatient dermatology
  • Urgent care dermatology
  • Teledermatology
  • Calciphylaxis
  • Pyoderma gangrenosum
  • Prurigo nodularis


Elsevier pure profile

Selected publications

  • Haynes D, Topham C, Hajar T, Ortega-Loayza AG, White KP, Keller JJ. Ulcerative C2 neurocutaneous dysesthesia (trigeminal trophic syndrome in an alternative distribution. Dermatol. Online J. 2020 26(1).
  • Dreicer, JJ, Keller J, Halvorson S. Clinical reasoning for a worsening rash: when you’re left with the diagnosis of exclusion. SGIM Forum 2020 43(3): 1-2.
  • Keller JJ, Johnson J, Latour E. Inpatient teledermatology: Diagnostic and therapeutic concordance among hospitalist, dermatologist, and teledermatologist using store-and-forward teledermatology. JAAD 2020 doi: 10.1016/j.jaad.2020.01.030. [Epub ahead of print]
  • Keller JJ, Fett NM, Morrison LH. Dermatology in the diagnosis of noncutaneous malignancy: paraneoplastic diseases. Dermatol Clin. 2019 37(4):537-44.
  • Haynes D, Hammer P, Malachowski SJ, Kaffenberger B, Yi JS, Vera N, Calhoun C, Shinohara M, Seminario-Vidal L, Trinidad JC, Keller JJ, Ortega-Loayza AG. Characterization and diagnosis of ulcers in inpatient dermatology consultation services: A multi-centre study. Int Wound J. 2019 doi:org/10.1111/iwj.13211 [Epub ahead of print]
  • Weinkle A, Pettit C, Jani A, Keller J, Lu Y, Malachowski S, Trinidad JC, Kaffenberger BH, Ergen EN, Hughey LC, Smith D, Seminario-Vidal L. Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation – a retrospective chart review. J Am Acad Dermatol. 2019 81(3):749-57.
  • Keller JJ, Ortega-Loayza AG. Do I have calciphylaxis? JAMA Dermatol 2019 May 22. Doi: 10.1001/jamadermatol.2019.0458. [Epub ahead of print]
  • Haag CK, Ortega-Loayza AG, Latour E, Keller JJ, Fett NM. Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum. J Dermatolog Treat 2019 Apr 18:1-4. doi: 10.1080/09546634.2019.1606888. [Epub ahead of print]
  • McClatchey TM, Haynes D, Korcheva VB, Keller J. Acrokeratosis paraneoplastica (Bazex syndrome) associated with peripheral T-cell lymphoma. JAAD Case Rep. 2019; 5(1):86-8.
  • Sanchez IM, Lowenstein S, Johnson KA, Babik J, Haag C, Keller JJ, Ortega-Loayza AG, Cohen J, McCalmont TH, Demer AM, Mansh MD, Hylwa SA, Liu J, Shinkai K. Clinical Features of Neutrophilic Dermatosis Variants Resembling Necrotizing Fasciitis. JAMA Dermatol 2019; 155(1):79-84.


  • {{ pub.journalAssociation.journal.name.text[0].value }}